Skip to main content

Animations

MJFF Publications

6281 - 6290 of 8818 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2019
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Symptom burden among individuals with Parkinson disease
    Journal Name: Neurology Clinical Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/cpj.0000000000000746
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants
    Journal Name: Neurology Clinical Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/cpj.0000000000000680
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Serum FGF-21, GDF-15, and blood mtDNA copy number are not biomarkers of Parkinson disease
    Journal Name: Neurology Clinical Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/cpj.0000000000000702
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Genetic architecture of subcortical brain structures in 38,851 individuals
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41588-019-0511-y
    Citation Count: 253
  • Summary Details
    OPEN
    Title: Validation of a Parkinson Disease Predictive Model in a Population-Based Study
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2020/2857608
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model
    Journal Name: BMC Research Notes
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13104-020-04994-7
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41586-020-1984-7
    Citation Count: 661
  • Summary Details
    OPEN
    Title: Initiation and propagation of α-synuclein aggregation in the nervous system
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-020-00368-6
    Citation Count: 245
  • Summary Details
    OPEN
    Title: A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer’s disease
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-020-01750-3
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-020-15119-w
    Citation Count: 409
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.